These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16899857)

  • 41. Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation Trial.
    Schulman S; Lindmarker P
    N Engl J Med; 2000 Jun; 342(26):1953-8. PubMed ID: 10874063
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Survival benefits of oral anticoagulants in patients with pulmonary arterial hypertension: Protocol for a systematic review and meta-analysis.
    Zhang HC; Wang N; Zhang W; Gu ZC; Liu XY
    Medicine (Baltimore); 2018 Sep; 97(36):e12203. PubMed ID: 30200129
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Are anticoagulants still indicated in pulmonary arterial hypertension?
    Olschewski H; Rich S
    Pulm Circ; 2018; 8(4):2045894018807681. PubMed ID: 30284508
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The noncanonical WNT pathway is operative in idiopathic pulmonary arterial hypertension.
    Laumanns IP; Fink L; Wilhelm J; Wolff JC; Mitnacht-Kraus R; Graef-Hoechst S; Stein MM; Bohle RM; Klepetko W; Hoda MA; Schermuly RT; Grimminger F; Seeger W; Voswinckel R
    Am J Respir Cell Mol Biol; 2009 Jun; 40(6):683-91. PubMed ID: 19029018
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognosis and response to first-line single and combination therapy in pulmonary arterial hypertension.
    Kylhammar D; Persson L; Hesselstrand R; Rådegran G
    Scand Cardiovasc J; 2014 Aug; 48(4):223-33. PubMed ID: 24912571
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The efficacy of bosentan in inoperable chronic thromboembolic pulmonary hypertension: a 1-year follow-up study.
    Hughes RJ; Jais X; Bonderman D; Suntharalingam J; Humbert M; Lang I; Simonneau G; Pepke-Zaba J
    Eur Respir J; 2006 Jul; 28(1):138-43. PubMed ID: 16611652
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension].
    Tatsumi K; Nakanishi N; Tanabe N; Kasahara Y; Kubo K; Hirai T; Mishima M
    Nihon Kokyuki Gakkai Zasshi; 2010 Aug; 48(8):551-64. PubMed ID: 20803971
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry).
    Barst RJ; Ivy DD; Foreman AJ; McGoon MD; Rosenzweig EB
    Am J Cardiol; 2014 Jan; 113(1):147-55. PubMed ID: 24176071
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Medical therapies for chronic thromboembolic pulmonary hypertension: an evolving treatment paradigm.
    Bresser P; Pepke-Zaba J; Jaïs X; Humbert M; Hoeper MM
    Proc Am Thorac Soc; 2006 Sep; 3(7):594-600. PubMed ID: 16963540
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pulmonary arteriopathy and idiopathic pulmonary arterial hypertension in six dogs.
    Zabka TS; Campbell FE; Wilson DW
    Vet Pathol; 2006 Jul; 43(4):510-22. PubMed ID: 16846993
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pulmonary arterial capacitance in children with idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease: relation to pulmonary vascular resistance, exercise capacity, and survival.
    Sajan I; Manlhiot C; Reyes J; McCrindle BW; Humpl T; Friedberg MK
    Am Heart J; 2011 Sep; 162(3):562-8. PubMed ID: 21884877
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long term anticoagulation of idiopathic venous thromboembolism: do we have the answers?
    Goldhaber S
    Clin Adv Hematol Oncol; 2003 May; 1(5):276-7. PubMed ID: 16224420
    [No Abstract]   [Full Text] [Related]  

  • 53. Nailfold capillary density is associated with the presence and severity of pulmonary arterial hypertension in systemic sclerosis.
    Hofstee HM; Vonk Noordegraaf A; Voskuyl AE; Dijkmans BA; Postmus PE; Smulders YM; Serné EH
    Ann Rheum Dis; 2009 Feb; 68(2):191-5. PubMed ID: 18375538
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pulmonary arterial hypertension in adults with congenital heart disease: distinct differences from other causes of pulmonary arterial hypertension and management implications.
    Dimopoulos K; Giannakoulas G; Wort SJ; Gatzoulis MA
    Curr Opin Cardiol; 2008 Nov; 23(6):545-54. PubMed ID: 18830068
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevention and treatment of the post-thrombotic syndrome and of the chronic thromboembolic pulmonary hypertension.
    Pesavento R; Prandoni P
    Expert Rev Cardiovasc Ther; 2015 Feb; 13(2):193-207. PubMed ID: 25577951
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Whither Anticoagulation in Pulmonary Arterial Hypertension? Conflicting Evidence REVEALed.
    Frantz RP
    Circulation; 2015 Dec; 132(25):2360-2. PubMed ID: 26510695
    [No Abstract]   [Full Text] [Related]  

  • 57. Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension.
    Mathai SC; Girgis RE; Fisher MR; Champion HC; Housten-Harris T; Zaiman A; Hassoun PM
    Eur Respir J; 2007 Mar; 29(3):469-75. PubMed ID: 17079256
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proinflammatory Signature of the Dysfunctional Endothelium in Pulmonary Hypertension. Role of the Macrophage Migration Inhibitory Factor/CD74 Complex.
    Le Hiress M; Tu L; Ricard N; Phan C; Thuillet R; Fadel E; Dorfmüller P; Montani D; de Man F; Humbert M; Huertas A; Guignabert C
    Am J Respir Crit Care Med; 2015 Oct; 192(8):983-97. PubMed ID: 26203495
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of baseline characteristics and survival between patients with idiopathic and connective tissue disease-related pulmonary arterial hypertension.
    Ruiz-Cano MJ; Escribano P; Alonso R; Delgado J; Carreira P; Velazquez T; Sanchez MA; Sáenz de la Calzada C
    J Heart Lung Transplant; 2009 Jun; 28(6):621-7. PubMed ID: 19481024
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Results of one-year anticoagulation in patients with newly detected chronic thromboembolic pulmonary hypertension not treated with pulmonary endarterectomy.
    Romaszkiewicz R; Lewczuk J; Piszko P; Jagas J; Lenartowska L; Ludwik B; Sawa W; Wrabec K
    Kardiol Pol; 2006 Nov; 64(11):1196-202; discussion 1203-4. PubMed ID: 17165160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.